Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched last week (Friday 15 September 2023).This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at t

Related Keywords

Saudi Arabia ,South Korea ,United Kingdom ,Oxford Astrazeneca ,Abu Dhabi ,Andrea Collins ,Maheshi Ramasamy ,Melanie Saville ,Dame Sarah Gilbert ,University Of Oxford Pandemic Sciences Institute ,World Health Organization ,University Of Oxford Vaccine Group ,University Of Oxford ,Liverpool School Of Tropical Medicine ,Liverpool University Hospitals ,Vaccine Research Development ,Oxford Vaccine Group ,Middle East Respiratory Syndrome ,Pandemic Sciences ,Middle East ,Pandemic Sciences Institute ,Liverpool School ,Tropical Medicine ,Clinical Research Facility ,Royal Liverpool University ,Executive Director ,Vaccine Research ,Senior Clinical Lecturer ,Respiratory Medicine ,Principal Investigator ,Clinician Scientist ,Chief Investigator ,